KIT and ovarian carcinoma: While not specifically studied in MCs, a connection with KIT, the principal receptor tyrosine kinase of MCs, was recently reported, whereby KIT activation in ovarian cancer stem cells could stabilize Notch Receptor 3 (NOTCH3) and thereby increase the downstream target PBX1 [222].